Consequently, HDAC5 inhibitors have the potential to serve as a novel treatment for diabetes by increasing the expression of the GLUT4 gene [10].‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬. Here, SLC2A4 is linked to diabetes mellitus.